Walthausen & Co. LLC decreased its holdings in shares of HealthSouth Corporation (NYSE:HLS) by 4.4% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 145,152 shares of the company’s stock after selling 6,630 shares during the period. Walthausen & Co. LLC owned approximately 0.15% of HealthSouth Corporation worth $7,025,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. First Mercantile Trust Co. grew its stake in shares of HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after acquiring an additional 430 shares during the last quarter. Acrospire Investment Management LLC grew its stake in shares of HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after acquiring an additional 1,100 shares during the last quarter. Advisor Group Inc. grew its stake in shares of HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after acquiring an additional 781 shares during the last quarter. Petrus Trust Company LTA purchased a new stake in shares of HealthSouth Corporation during the second quarter worth about $210,000. Finally, HL Financial Services LLC purchased a new stake in shares of HealthSouth Corporation during the second quarter worth about $213,000. Institutional investors and hedge funds own 93.05% of the company’s stock.
Shares of HealthSouth Corporation (HLS) traded up 0.46% during midday trading on Wednesday, reaching $45.50. The company had a trading volume of 87,767 shares. The stock has a market capitalization of $4.49 billion, a PE ratio of 16.55 and a beta of 0.58. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71. The company’s 50 day moving average price is $45.04 and its 200 day moving average price is $45.33.
HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. During the same quarter last year, the business posted $0.69 EPS. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. Equities research analysts expect that HealthSouth Corporation will post $2.71 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a $0.25 dividend. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is 36.76%.
HLS has been the topic of a number of research analyst reports. Piper Jaffray Companies restated a “hold” rating and set a $50.00 price target on shares of HealthSouth Corporation in a research note on Thursday, August 3rd. Zacks Investment Research lowered HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Robert W. Baird restated a “buy” rating and set a $55.00 price target on shares of HealthSouth Corporation in a research note on Monday. ValuEngine lowered HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Finally, KeyCorp initiated coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They set a “sector weight” rating on the stock. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $50.38.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of HealthSouth Corporation stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $42.55, for a total value of $962,693.75. Following the transaction, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,047,351.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.
HealthSouth Corporation Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.